What's New in Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 33, Issue 8, 2019, Pages 2296-2326

  Hessel, Eugene A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

activated coagulation time; cardiopulmonary bypass; cognitive decline; delirium; kidney injury; tranexamic acid; transesophageal echocardiography; vasoplegia

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRINOGEN CONCENTRATE; HETASTARCH; LEVOSIMENDAN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACUTE KIDNEY FAILURE; ANEMIA; ANESTHESIOLOGIST; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULATION; ARTICLE; AUTOREGULATION; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD TRANSFUSION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DELIRIUM; ERYTHROCYTE PRESERVATION; FEMORAL ARTERY; HEART SURGERY; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; MANAGEMENT; MEAN ARTERIAL PRESSURE; MEAN CORPUSCULAR VOLUME; MYCOBACTERIOSIS; MYCOBACTERIUM CHIMAERA; PERFUSION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COGNITIVE DYSFUNCTION; POSTOPERATIVE DELIRIUM; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREGNANCY; PRESSURE GRADIENT; PRIORITY JOURNAL; PROPHYLACTIC SURGICAL PROCEDURE; RADIAL ARTERY; SEIZURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASOPLEGIA; CARDIOVASCULAR DISEASE; DIAGNOSTIC IMAGING; PROCEDURES;

CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 85063385271     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2019.01.039     Document Type: Article

References (235)

1. Herron, P.W., Thomas, G.I., Jesseph, J.E., et al. Successful open cardiac surgery; a mechanical pump oxygenator system. Q Rev Surg 14 (1957), 113–116.
2. Hessel, E.A., History of cardiopulmonary bypass (CPB). Best Pract Res Clin Anaesthesiol 29 (2015), 99–111.
3. Murphy, G.S., Hessel, E.A. 2nd, Groom, R.C., Optimal perfusion during cardiopulmonary bypass: An evidence-based approach. Anesth Analg 108 (2009), 1394–1417.
4. Bartels, C., Gerdes, A., Babin-Ebell, J., et al. Cardiopulmonary bypass: Evidence or experience based?. J Thorac Cardiovasc Surg 124 (2002), 20–27.
5. Gravlee, G.P., Davis, R.G., Hammon, J.W., et al. Cardiopulmonary bypass and mechanical circulatory support. ed 4, 2016, Wolters Kluwer, Philadelphia, PA.
6. Gravlee, G.P., Shaw, A.D., Bartels, K., Hensley's practical approach to cardiothoracic anesthesia. ed 6, 2019, Wolters Kluwer, Philadelphia, PA.
7. Landoni, G., Lomivorotov, V., Silvietti, S., et al. Nonsurgical strategies to reduce mortality in patients undergoing cardiac surgery: An updated consensus process. J Cardiothorac Vasc Anesth 32 (2018), 225–235.
8. Engelman, R., Baker, R.A., Likosky, D.S., et al. The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: Clinical practice guidelines for cardiopulmonary bypass—temperature management during cardiopulmonary bypass. Ann Thorac Surg 100 (2015), 748–757.
9. Purza, R., Ghosh, S., Walker, C., et al. Transesophageal echocardiography complications in adult cardiac surgery: A retrospective cohort study. Ann Thorac Surg 103 (2017), 795–802.
10. Hogue, C.W. Jr, Lappas, G.D., Creswell, L.L., et al. Swallowing dysfunction after cardiac operations. Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg 110 (1995), 517–522.
11. Rousou, J.A., Tighe, D.A., Garb, J.L., et al. Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg 69 (2000), 486–489.
12. Chin, J.H., Lee, E.H., Choi, D.K., et al. A modification of the trans-oesophageal echocardiography protocol can reduce post-operative dysphagia following cardiac surgery. J Int Med Res 39 (2011), 96–104.
13. Ivascu, N.S., Meltzer, E.C., Teacher and trustee: Examining the ethics of experiential learning in transesophageal echocardiography education. Anesth Analg 126 (2018), 1077–1080.
14. Shore-Lesserson, L., Baker, R.A., Ferraris, V.A., et al. The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: Clinical practice guidelines-anticoagulation during cardiopulmonary bypass. Ann Thorac Surg 105 (2018), 650–662.
15. Miles, L.F., Coulson, T.G., Galhardo, C., et al. Pump priming practices and anticoagulation in cardiac surgery: Results from the Global Cardiopulmonary Bypass Survey. Anesth Analg 125 (2017), 1871–1877.
16. Lobato, R.L., Despotis, G.J., Levy, J.H., et al. Anticoagulation management during cardiopulmonary bypass: A survey of 54 North American institutions. J Thorac Cardiovasc Surg 139 (2010), 1665–1666.
17. Bull, B.S., Korpman, R.A., Huse, W.M., et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 69 (1975), 674–684.
18. Bull, B.S., Huse, W.M., Brauer, F.S., et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 69 (1975), 685–689.
19. Boer, C., Meesters, M.I., Milojevic, M., et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth 32 (2018), 88–120.
20. Baker, R.A., Bronson, S.L., Dickinson, T.A., et al. American Society of Extracorporeal Technology standards and guidelines for perfusion practice: 2013. J Extra Corpor Technol 45 (2013), 156–166.
21. Schell, R.M., Kern, F.H., Greeley, W.J., et al. Cerebral blood flow and metabolism during cardiopulmonary bypass. Anesth Analg 76 (1993), 849–865.
22. Govier, A.V., Reves, J.G., McKay, R.D., et al. Factors and their influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypass. Ann Thorac Surg 38 (1984), 592–600.
23. Gold, J.P., Charlson, M.E., Williams-Russo, P., et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 110 (1995), 1302–1311.
24. Siepe, M., Pfeiffer, T., Gieringer, A., et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg 40 (2011), 200–207.
25. Vedel, A.G., Holmgaard, F., Rasmussen, L.S., et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: A randomized controlled trial. Circulation 137 (2018), 1770–1780.
26. Cheung, A.T., Messé, S.B., Preventing brain injury after cardiopulmonary bypass will require more than just dialing up the pressure. Circulation 137 (2018), 1781–1783.
27. Sun, L.Y., Chung, A.M., Farkouh, M.E., et al. Defining an intraoperative hypotension threshold in association with stroke in cardiac surgery. Anesthesiology 129 (2018), 440–447.
28. Joshi, B., Ono, M., Brown, C., et al. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg 114 (2012), 503–510.
29. Hori, D., Nomura, Y., Ono, M., et al. Optimal blood pressure during cardiopulmonary bypass defined by cerebral autoregulation monitoring. J Thorac Cardiovasc Surg 154 (2017), 1590–1598.
30. Ono, M., Brady, K., Easley, R.B., et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg 147 (2014), 483–489.
31. Hori, D., Brown, C., Ono, M., et al. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth 113 (2014), 1009–1017.
32. Hori, D., Max, L., Laflam, A., et al. Blood pressure deviations from optimal mean arterial pressure during cardiac surgery measured with a novel monitor of cerebral blood flow and risk for perioperative delirium: A pilot study. J Cardiothorac Vasc Anesth 30 (2016), 606–612.
33. Rivera-Lara, L., Zorrilla-Vaca, A., Healy, R.J., et al. Determining the upper and lower limits of cerebral autoregulation with cerebral oximetry autoregulation curves: A case series. Crit Care Med 46 (2018), e473–e477.
34. Chan, J.L., Kobashigawa, J.A., Aintablian, T.L., et al. Characterizing predictors and severity of vasoplegia syndrome after heart transplantation. Ann Thorac Surg 105 (2018), 770–777.
35. Jentzer, J.C., Vallabhajosyula, S., Khanna, A.K., et al. Management of refractory vasodilatory shock. Chest 154 (2018), 416–426.
36. Lambden, S., Creagh-Brown, B.C., Hunt, J., et al. Definitions and pathophysiology of vasoplegic shock. Crit Care, 22, 2018, 174.
37. Shaefi, S., Mittel, A., Klick, J., et al. Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth 32 (2018), 1013–1022.
38. Liu, H., Yu, L., Yang, L., et al. Vasoplegic syndrome: An update on perioperative considerations. J Clin Anesth 40 (2017), 63–71.
39. Tsiouris, A., Wilson, L., Haddadin, A.S., et al. Risk assessment and outcomes of vasoplegia after cardiac surgery. Gen Thorac Cardiovasc Surg 65 (2017), 557–565.
40. Omar, S., Zedan, A., Nugent, K., Cardiac vasoplegia syndrome: Pathophysiology, risk factors and treatment. Am J Med Sci 349 (2015), 80–88.
41. Fischer, G.W., Levin, M.A., Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 22 (2010), 140–144.
42. Sun, X., Boyce, S.W., Herr, D.L., et al. Is vasoplegic syndrome more prevalent with open-heart procedures compared with isolated on-pump CABG surgery?. Cardiovasc Revasc Med 12 (2011), 203–209.
43. Sun, X., Zhang, L., Hill, P.C., et al. Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?. Eur J Cardiothorac Surg 34 (2008), 820–825.
44. Hajjar, L.A., Vincent, J.L., Barbosa Gomes Galas, F.R., et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial. Anesthesiology 126 (2017), 85–93.
45. Dünser, M.W., Bouvet, O., Knotzer, H., et al. Vasopressin in cardiac surgery: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 32 (2018), 2225–2232.
46. McCartney, S.L., Duce, L., Ghadimi, K., Intraoperative vasoplegia: Methylene blue to the rescue!. Curr Opin Anaesthesiol 31 (2018), 43–49.
47. Hosseinian, L., Weiner, M., Levin, M.A., et al. Methylene blue: Magic bullet for vasoplegia?. Anesth Analg 122 (2016), 194–201.
48. Evora, P.R., Alves Junior, L., Ferreira, C.A., et al. Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised. Rev Bras Cir Cardiovasc 30 (2015), 84–92.
49. Chan, B.S., Becker, T., Chiew, A.L., et al. Vasoplegic shock treated with methylene blue complicated by severe serotonin syndrome. J Med Toxicol 14 (2018), 100–103.
50. Haacker, L., Maliekel, M., Bardsley, C.E.H., et al. Serotonin syndrome following septal myectomy in association with fentanyl and methylene blue: A case report. Psychosomatics 59 (2018), 512–516.
51. Schumacher, L.D., Blumer, V., Chaparro, S.V., Methylene blue-induced serotonin syndrome after left ventricular assist device implantation: A case report and literature review. J Thorac Cardiovasc Surg 154 (2017), e39–e43.
52. Boettcher, B.T., Woehlck, H.J., Reck, S.E., et al. Treatment of vasoplegic syndrome with intravenous hydroxocobalamin during liver transplantation. J Cardiothorac Vasc Anesth 31 (2017), 1381–1384.
53. Woehlck, H.J., Boettcher, B.T., Lauer, K.K., et al. Hydroxocobalamin for vasoplegic syndrome in liver transplantation: Restoration of blood pressure without vasospasm. A A Case Rep 7 (2016), 247–250.
54. Roderique, J.D., VanDyck, K., Holman, B., et al. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Ann Thorac Surg 97 (2014), 1785–1786.
55. Burnes, M.L., Boettcher, B.T., Woehlck, H.J., et al. Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass. J Cardiothorac Vasc Anesth 31 (2017), 1012–1014.
56. Zundel, M.T., Feih, J.T., Rinka, J.R.G., et al. Hydroxocobalamin with or without methylene blue may improve fluid balance in critically ill patients with vasoplegic syndrome after cardiac surgery: A report of two cases. J Cardiothorac Vasc Anesth 32 (2018), 452–457.
57. Shah, P.R., Reynolds, P.S., Pal, N., et al. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: A case series. Can J Anaesth 65 (2018), 560–568.
58. Warner, M.A., Mauermann, W.J., Armour, S., et al. Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome. Can J Anaesth 64 (2017), 673–674.
59. Wieruszewski, P.M., Nei, S.D., Maltais, S., et al. Vitamin C for vasoplegia after cardiopulmonary bypass: A case series. A A Pract 11 (2018), 96–99.
60. Honore, P.M., Jacobs, R., Hendrickx, I., et al. Adjuvant vitamin C treatment in sepsis-how many oranges a day keep (vasopressor-dependent) septic shock away?. J Thorac Dis 8 (2016), E993–E995.
61. Marik, P.E., Vitamin C for the treatment of sepsis: The scientific rationale. Pharmacol Ther 189 (2018), 63–70.
62. Khanna, A., English, S.W., Wang, X.S., et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377 (2017), 419–430.
63. Buchtele, N., Schwameis, M., Jilma, B., Angiotensin II for the treatment of vasodilatory shock: Enough data to consider angiotensin II safe?. Crit Care, 22, 2018, 96.
64. Busse, L.W., Wang, X.S., Chalikonda, D.M., et al. Clinical experience with IV angiotensin II administration: A systematic review of safety. Crit Care Med 45 (2017), 1285–1294.
65. Busse, L.W., McCurdy, M.T., Ali, O., et al. The effect of angiotensin II on blood pressure in patients with circulatory shock: A structured review of the literature. Crit Care, 21, 2017, 324.
66. Bussard, R.L., Busse, L.W., Angiotensin II: A new therapeutic option for vasodilatory shock. Ther Clin Risk Manag 14 (2018), 1287–1298.
67. Chow, J.H., Galvagno, S.M. Jr, Tanaka, K.A., et al. When all else fails: Novel use of angiotensin II for vasodilatory shock: A case report. A A Pract 11 (2018), 175–180.
68. Tumlin, J.A., Murugan, R., Deane, A.M., et al. Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med 46 (2018), 949–957.
69. Wakefield, B.J., Sacha, G.L., Khanna, A.K., Vasodilatory shock in the ICU and the role of angiotensin II. Curr Opin Crit Care 24 (2018), 277–285.
70. Society of Thoracic Surgery Blood Conservation Guidelines Task Force Ferraris, V.A., Brown, J.R., et al. 2011 update to the Society of Thoracic Surgery and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. ATS 91 (2011), 944–982.
71. Levy, J.H., Koster, A., Quinones, Q.J., et al. Antifibrinolytic therapy and perioperative considerations. Anesthesiology 128 (2018), 657–670.
72. Gerstein, N.S., Brierley, J.K., Windsor, J., et al. Antifibrinolytic agents in cardiac and noncardiac surgery: A comprehensive overview and update. J Cardiothorac Vasc Anesth 31 (2017), 2183–2205.
73. Koster, A., Faraoni, D., Levy, J.H., Antifibrinolytic therapy for cardiac surgery: An update. Anesthesiology 123 (2015), 214–221.
74. Horrow, J.C., Van Riper, D.F., Strong, M.D., et al. The dose-response relationship of tranexamic acid. Anesthesiology 82 (1995), 383–392.
75. Dowd, N.P., Karski, J.M., Cheng, D.C., et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 97 (2002), 390–399.
76. Fergusson, D.A., Hébert, P.C., Mazer, C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008), 2319–2331.
77. Myles, P.S., Smith, J.A., Forbes, A., et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376 (2017), 136–148.
78. Jerath, A., Yang, Q.J., Pang, K.S., et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: A new dosing regimen. Anesth Analg 127 (2018), 1323–1332.
79. Spence, J., Long, S., Tidy, A., et al. Tranexamic acid administration during on-pump cardiac surgery: A survey of current practices among Canadian anesthetists working in academic centers. Anesth Analg 125 (2017), 1863–1870.
80. Santos, A.T., Kalil, R.A., Bauemann, C., et al. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Braz J Med Biol Res 39 (2006), 63–69.
81. Waldow, T., Szlapka, M., Haferkorn, M., et al. Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures. Clin Hemorheol Microcirc 55 (2013), 457–468.
82. Karski, J.M., Dowd, N.P., Joiner, R., et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). J Cardiothorac Vasc Anesth 12 (1998), 642–646.
83. Sigaut, S., Tremey, B., Ouattara, A., et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 120 (2014), 590–600.
84. Casati, V., Della Valle, P., Benussi, S., et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 128 (2004), 83–91.
85. Pataraia, E., Jung, R., Aull-Watschinger, S., et al. Seizures after adult cardiac surgery and interventional cardiac procedures. J Cardiothorac Vasc Anesth 32 (2018), 2323–2329.
86. Goldstone, A.B., Bronster, D.J., Anyanwu, A.C., et al. Predictors and outcomes of seizures after cardiac surgery: A multivariable analysis of 2,578 patients. Ann Thorac Surg 91 (2011), 514–518.
87. Martin, K., Wiesner, G., Breuer, T., et al. The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients. Anesth Analg 107 (2008), 1783–1790.
88. Murkin, J.M., Falter, F., Granton, J., et al. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 110 (2010), 350–353.
89. Bell, D., Marasco, S., Almeida, A., et al. Tranexamic acid in cardiac surgery and postoperative seizures: A case report series. Heart Surg Forum 13 (2010), E257–E259.
90. Berman, M.1, Cardone, D., Sharples, L., et al. Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: Review of 200 patients. Ann Thorac Surg 90 (2010), 1432–1436.
91. Martin, K., Knorr, J., Breuer, T., et al. Seizures after open heart surgery: Comparison of ε-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth 25 (2011), 20–25.
92. Keyl, C., Uhl, R., Beyersdorf, F., et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 39 (2011), e114–e121.
93. Manji, R.A., Grocott, H.P., Leake, J., et al. Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors. Can J Anaesth 59 (2012), 6–13.
94. Kalavrouziotis, D., Voisine, P., Mohammadi, S., et al. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 93 (2012), 148–154.
95. Sharma, V., Katznelson, R., Jerath, A., et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: A multivariate analysis in 11 529 patients. Anaesthesia 69 (2014), 124–130.
96. Couture, P., Lebon, J.S., Laliberté, É., et al. Low-dose versus high-dose tranexamic acid reduces the risk of nonischemic seizures after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 31 (2017), 1611–1617.
97. Lin, Z., Xiaoyi, Z., Tranexamic acid-associated seizures: A meta-analysis. Seizure 36 (2016), 70–73.
98. Takagi, H., Ando, T., Umemoto, T., Seizures associated with tranexamic acid for cardiac surgery: A meta-analysis of randomized and non-randomized studies. J Cardiovasc Surg (Torino) 58 (2017), 633–641.
99. Lecker, I., Wang, D.S., Romaschin, A.D., et al. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 122 (2012), 4654–4666.
100. Maeda, T., Sasabuchi, Y., Matsui, H., et al. Safety of tranexamic acid in pediatric cardiac surgery: A nationwide database study. J Cardiothorac Vasc Anesth 31 (2017), 549–553.
101. Goobie, S.M., Tranexamic acid: Still far to go (editorial). BJA 118 (2017), 293–295.
102. Bridges, K.H., Wilson, S.H., Acute coronary artery thrombus after tranexamic acid during total shoulder arthroplasty in a patient with coronary stents: A case report. A A Pract 10 (2018), 212–214.
103. Benedetto, U., Altman, D.G., Gerry, S., et al. Safety of perioperative aprotinin administration during isolated coronary artery bypass graft surgery: Insights from the ART (Arterial Revascularization Trial). J Am Heart Assoc, 7(5), 2018.
104. Gerstein, N.S., Deriy, L., Patel, P.A., Tranexamic acid use in cardiac surgery: Hemostasis, seizures, or a little of both. J Cardiothorac Vasc Anesth 32 (2018), 1635–1637.
105. LaPar, D.J., Hawkins, R.B., McMurry, T.L., et al. Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery?. J Thorac Cardiovasc Surg 156 (2018), 66–74.
106. Murphy, G.J., Pike, K., Rogers, C.A., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
107. Koch, C.G., Sessler, D.I., Mascha, E.J., et al. A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg 104 (2017), 1243–1250.
108. Mazer, C.D., Whitlock, R.P., Fergusson, D.A., et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 377 (2017), 2133–2144.
109. Mazer, C.D., Whitlock, R.P., Fergusson, D.A., et al. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med 379 (2018), 1224–1233.
110. Crawford, T.C., Magruder, J.T., Fraser, C., et al. Less is more: Results of a statewide analysis of the impact of blood transfusion on coronary artery bypass grafting outcomes. Ann Thorac Surg 105 (2018), 129–136.
111. Koch, C.G., Li, L., Sessler, D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 (2008), 1229–1239.
112. Alexander, P.E., Barty, R., Fei, Y., et al. Transfusion of fresher vs older red blood cells in hospitalized patients: A systematic review and meta-analysis. Blood 127 (2016), 400–410.
113. Chai-Adisaksopha, C., Alexander, P.E., Guyatt, G., et al. Mortality outcomes in patients transfused with fresher versus older red blood cells: A meta-analysis. Vox Sang 112 (2017), 268–278.
114. Steiner, M.E., Ness, P.M., Assmann, S.F., et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 372 (2015), 1419–1429.
115. Heddle, N.M., Cook, R.J., Arnold, D.M., et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 375 (2016), 1937–1945.
116. Lacroix, J., Hébert, P.C., Fergusson, D.A., et al. Age of transfused blood in critically ill adults. N Engl J Med 372 (2015), 1410–1418.
117. Ng, M.S.Y., David, M., Middelburg, R.A., et al. Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials. Haematologica 103 (2018), 1542–1548.
118. Cartotto, R., Taylor, S.L., Holmes, J.H. 4th, et al. The effects of storage age of blood in massively transfused burn patients: A secondary analysis of the randomized Transfusion Requirement in Burn Care Evaluation Study. Crit Care Med 46 (2018), e1097–e1104.
119. Dai, L., Mick, S.L., McCrae, K.R., et al. Preoperative anemia in cardiac operation: Does hemoglobin tell the whole story?. Ann Thorac Surg 105 (2018), 100–107.
120. Ghadimi, K., Welsby, I.J., Pro: Factor concentrates are essential for hemostasis in complex cardiac surgery. J Cardiothorac Vasc Anesth 33 (2018), 558–564.
121. Patel, P.A., Fabbro, M. 2nd, Con: Factor concentrates should not have an expanded role in the routine management of the bleeding cardiac surgical patient. J Cardiothorac Vasc Anesth 32 (2018), 565–569.
122. Bhatt, H.V., Subramaniam, K., Pro: Prothrombin complex concentrate should be used in preference to fresh frozen plasma for hemostasis in cardiac surgical patients. J Cardiothorac Vasc Anesth 32 (2018), 1062–1067.
123. Raleith, L., Cole, S.P., Con: Factor concentrate usage in cardiac surgery-A paucity of data limits their universal adoption. Cardiothorac Vasc Anesth 32 (2018), 1068–1071.
124. Li, J.Y., Gong, J., Zhu, F., et al. Fibrinogen concentrate in cardiovascular surgery: A meta-analysis of randomized controlled trials. Anesth Analg 127 (2018), 612–621.
125. Henderson, R.A., Mazzeffi, M.A., Tanaka, K.A., Fibrinogen concentrate: Is it standard currency or Bitcoin in bleeding management?. Anesth Analg 127 (2018), 603–604.
126. Karkouti, K., Arellano, R., Aye, T., et al. Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report). Can J Anaesth 61 (2014), 727–735.
127. Mazer, C.D., Blood conservation in cardiac surgery: Guidelines and controversies. Transfus Apher Sci 50 (2014), 20–25.
128. Chapman, A.J., Blount, A.L., Davis, A.T., et al. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. Eur J Cardiothorac Surg 40 (2011), 1314–1318 discussion 1318-9.
129. Alfirevic, A., Duncan, A., You, J., et al. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg 98 (2014), 618–624.
130. Downey, L., Brown, M.L., Faraoni, D., et al. Recombinant factor VIIa is associated with increased thrombotic complications in pediatric cardiac surgery patients. Anesth Analg 124 (2017), 1431–1436.
131. Habib, A.M., Calafiore, A.M., Cargoni, M., et al. Recombinant activated factor VII is associated with postoperative thromboembolic adverse events in bleeding after coronary surgery. Interact Cardiovasc Thorac Surg 27 (2018), 350–356.
132. Habib, A.M., Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding. Indian J Crit Care Med 20 (2016), 497–503.
133. Hoffmann, T., Assmann, A., Dierksen, A., et al. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study. J Thorac Cardiovasc Surg, 156, 2018 1564-73.e8.
134. Harper, P.C., Smith, M.M., Brinkman, N.J., et al. Outcomes following three-factor inactive prothrombin complex concentrate versus recombinant activated factor VII administration during cardiac surgery. J Cardiothorac Vasc Anesth 32 (2018), 151–157.
135. Vandenberghe, W., Gevaert, S., Kellum, J.A., et al. Acute kidney injury in cardiorenal syndrome type 1 patients: A systematic review and meta-analysis. Cardiorenal Med 6 (2016), 116–128.
136. Zarbock, A., Koyner, J.L., Hoste, E.A.J., et al. Update on perioperative acute kidney injury. Anesth Analg 127 (2018), 1236–1245.
137. O'Neal, J.B., Shaw, A.D., Billings, F.T. 4th, Acute kidney injury following cardiac surgery: Current understanding and future directions. Crit Care, 20, 2016, 187.
138. Hoste, E.A.J., Vandenberghe, W., Epidemiology of cardiac surgery-associated acute kidney injury. Best Pract Res Clin Anaesthesiol 31 (2017), 299–303.
139. Vandenberghe, W., De Loor, J., Hoste, E.A., Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers. Curr Opin Anaesthesiol 30 (2017), 66–75.
140. Meersch, M., Schmidt, C., Van Aken, H., et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One, 9, 2014, e93460.
141. McIlroy, D.R., Farkas, D., Pan, K., et al. Combining novel renal injury markers with delta serum creatinine early after cardiac surgery and risk-stratification for serious adverse outcomes: An exploratory analysis. J Cardiothorac Vasc Anesth 32 (2018), 2190–2200.
142. Puskas, J.D., Martin, J., Cheng, D.C., et al. ISMICS Consensus Conference and statements of randomized controlled trials of off-pump versus conventional coronary artery bypass surgery. Innovations (Phila) 1 (2015), 219–229.
143. Crawford, T.C., Magruder, J.T., Grimm, J.C., et al. Renal failure after cardiac operations: Not all acute kidney injury is the same. Ann Thorac Surg 104 (2017), 760–766.
144. Shiba, A., Uchino, S., Fujii, T., et al. Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 127 (2018), 1229–1235.
145. Mizota, T., Yamamoto, Y., Hamada, M., et al. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 119 (2017), 1127–1134.
146. Evans, R.G., Lankadeva, Y.R., Cochrane, A.D., et al. Renal haemodynamics and oxygenation during and after cardiac surgery and cardiopulmonary bypass. Acta Physiol (Oxf), 222(3), 2018.
147. Lannemyr, L., Bragadottir, G., Krumbholz, V., et al. Effects of cardiopulmonary bypass on renal perfusion, filtration, and oxygenation in patients undergoing cardiac surgery. Anesthesiology 126 (2017), 205–213.
148. Regolisti, G., Maggiore, U., Cademartiri, C., et al. Renal resistive index by transesophageal and transparietal echo-doppler imaging for the prediction of acute kidney injury in patients undergoing major heart surgery. J Nephrol 30 (2017), 243–253.
149. Andrew, B.Y., Andrew, E.Y., Cherry, A.D., et al. Intraoperative renal resistive index as an acute kidney injury biomarker: Development and validation of an automated analysis algorithm. J Cardiothorac Vasc Anesth 32 (2018), 2203–2209.
150. Andrew, B.Y., Cherry, A.D., Hauck, J.N., et al. The association of aortic valve pathology with renal resistive index as a kidney injury biomarker. Ann Thorac Surg 106 (2018), 107–114.
151. Newland, R.F., Baker, R.A., Mazzone, A.L., et al. Rewarming temperature during cardiopulmonary bypass and acute kidney injury: A multicenter analysis. Ann Thorac Surg 101 (2016), 1655–1662.
152. Newland, R.F., Baker, R.A., Low oxygen delivery as a predictor of acute kidney injury during cardiopulmonary bypass. J Extra Corpor Technol 49 (2017), 224–230.
153. Ranucci, M., Johnson, I., Willcox, T., et al. Goal-directed perfusion to reduce acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg, 156, 2018 1918-27.e2.
154. Magruder, J.T., Crawford, T.C., Harness, H.L., et al. A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg, 153, 2017 118-25.e1.
155. He, S.J., Liu, Q., Li, H.Q., et al. Role of statins in preventing cardiac surgery-associated acute kidney injury: An updated meta-analysis of randomized controlled trials. Ther Clin Risk Manag 14 (2018), 475–482.
156. Zangrillo, A., Alvaro, G., Belletti, A., Effect of levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: A substudy of a multicenter randomized trial. J Cardiothorac Vasc Anesth 32 (2018), 2152–2159.
157. Mehta, R.H., Leimberger, J.D., van Diepen, S., et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 376 (2017), 2032–2042.
158. Landoni, G., Lomivorotov, V.V., Alvaro, G., et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 376 (2017), 2021–2031.
159. Cholley, B., Caruba, T., Grosjean, S., et al. Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: The LICORN randomized clinical trial. JAMA 318 (2017), 548–556.
160. Putzu, A., Clivio, S., Belletti, A., et al. Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis. Int J Cardiol 251 (2018), 22–31.
161. Liu, Y., Sheng, B., Wang, S., et al. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: A meta-analysis of randomized controlled trials. BMC Anesthesiol, 18, 2018, 7.
162. Zhai, M., Kang, F., Han, M., et al. The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: A double-blind randomized controlled trial. J Clin Anesth 40 (2017), 33–38.
163. Meersch, M., Volmering, S., Zarbock, A., Prevention of acute kidney injury. Best Pract Res Clin Anaesthesiol 31 (2017), 361–370.
164. Meersch, M., Schmidt, C., Hoffmeier, A., et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43 (2017), 1551–1561.
165. Ferraris, V.A., Perfusion-induced acute kidney injury: A litany of uncertainty and frustration. J Thorac Cardivasc Surg 156 (2018), 1928–1931.
166. Berger, M., Terrando, N., Smith, K., et al. Neurocognitive function after cardiac surgery. From phenotypes to mechanisms. Anesthesiology 129 (2018), 829–851.
167. Evered, L., Silbert, B., Knopman, D.S., et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Anesthesiology 129 (2018), 872–879 Simultaneously published in Acta Anaesthesiol Scand. 2018 Nov;62:1473-1480, Anesth Analg. 2018 Nov;127:1189-1195, Br J Anaesth. 2018 Nov;121:1005-1012, Can J Anaesth. 2018 Nov;65:1248-1257, J Alzheimers Dis. 2018;66:1-10.
168. Berger, M., Schenning, K.J., Brown, C.H. 4th, et al. Best practices for postoperative brain health: Recommendations from the Fifth International Perioperative Neurotoxicity Working Group. Anesth Analg 127 (2018), 1406–1413.
169. Hamilton, G.M., Wheeler, K., Di Michele, J., et al. A systematic review and meta-analysis examining the impact of incident postoperative delirium on mortality. Anesthesiology 127 (2017), 78–88.
170. Hollinger, A., Siegemund, M., Goettel, N., et al. Postoperative delirium in cardiac surgery: An unavoidable menace?. J Cardiothorac Vasc Anesth 29 (2015), 1677–1687.
171. Evans, A.S., Weiner, M.M., Arora, R.C., et al. Current approach to diagnosis and treatment of delirium after cardiac surgery. Ann Card Anaesth 19 (2016), 328–337.
172. O'Neal, J.B., Shaw, A.D., Predicting, preventing, and identifying delirium after cardiac surgery. Perioper Med (Lond), 5, 2016, 7.
173. Arora, R.C., Djaiani, G., Rudolph, J.L., Detection, prevention, and management of delirium in the critically ill cardiac patient and patients who undergo cardiac procedures. Can J Cardiol 33 (2017), 80–87.
174. Crocker, E., Beggs, T., Hassan, A., et al. Long-term effects of postoperative delirium in patients undergoing cardiac operation: A systematic review. Ann Thorac Surg 102 (2016), 1391–1399.
175. Sauër, A.C., Veldhuijzen, D.S., Ottens, T.H., et al. Association between delirium and cognitive change after cardiac surgery. Br J Anaesth 119 (2017), 308–315.
176. Leenders, J., Overdevest, E., van Straten, B., et al. The influence of oxygen delivery during cardiopulmonary bypass on the incidence of delirium in CABG patients; a retrospective study. Perfusion 33 (2018), 656–662.
177. Järvelä, K., Porkkala, H., Karlsson, S., et al. Postoperative delirium in cardiac surgery patients. J Cardiothorac Vasc Anesth 32 (2018), 1597–1602.
178. Rudiger, A., Begdeda, H., Babic, D., et al. Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care, 20, 2016, 264.
179. Brown, C.H. 4th, Probert, J., Healy, R., et al. Cognitive decline after delirium in patients undergoing cardiac surgery. Anesthesiology 129 (2018), 406–416.
180. Smulter, N., Lingehall, H.C., Gustafson, Y., et al. Disturbances in oxygen balance during cardiopulmonary bypass: A risk factor for postoperative delirium. J Cardiothorac Vasc Anesth 32 (2018), 684–690.
181. Kotfis, K., Szylińska, A., Listewnik, M., et al. Early delirium after cardiac surgery: An analysis of incidence and risk factors in elderly (≥65 years) and very elderly (≥80 years) patients. Clin Interv Aging 13 (2018), 1061–1070.
182. Lingehall, H.C., Smulter, N.S., Lindahl, E., et al. Preoperative cognitive performance and postoperative delirium are independently associated with future dementia in older people who have undergone cardiac surgery: A longitudinal cohort study. Crit Care Med 45 (2017), 1295–1303.
183. Gosselt, A.N., Slooter, A.J., Boere, P.R., et al. Risk factors for delirium after on-pump cardiac surgery: A systematic review. Crit Care, 19, 2015, 346.
184. Bucerius, J., Gummert, J.F., Borger, M.A., et al. Predictors of delirium after cardiac surgery delirium: Effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg 127 (2004), 57–64.
185. O'Neal, J.B., Billings, F.T. 4th, Liu, X., et al. Risk factors for delirium after cardiac surgery: A historical cohort study outlining the influence of cardiopulmonary bypass. Can J Anaesth 64 (2017), 1129–1137.
186. Evered, L.A., Silbert, B.S., Postoperative cognitive dysfunction and noncardiac surgery. Anesth Analg 127 (2018), 496–505.
187. Bhamidipati, D., Goldhammer, J.E., Sperling, M.R., et al. Cognitive outcomes after coronary artery bypass grafting. J Cardiothorac Vasc Anesth 31 (2017), 707–718.
188. Kumpaitiene, B., Svagzdiene, M., Sirvinskas, E., et al. Cerebrovascular autoregulation impairments during cardiac surgery with cardiopulmonary bypass are related to postoperative cognitive deterioration: Prospective observational study. Minerva Anestesiol, 2018 May 11 [E-pub ahead of print].
189. Mack, M.J., Acker, M.A., Gelijns, A.C., et al. Effect of cerebral embolic protection devices on CNS infarction in surgical aortic valve replacement: A randomized clinical trial. JAMA 318 (2017), 536–547.
190. Chen, F., Duan, G., Wu, Z., et al. Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: A systematic review and meta-analysis. BMJ Open, 7, 2017, e014629.
191. Ottens, T.H., Dieleman, J.M., Sauër, A.M., et al. Effects of dexamethasone on cognitive decline after cardiac surgery: A randomized clinical trial. Anesthesiology 121 (2014), 492–500.
192. Glumac, S., Kardum, G., Sodic, L., et al. Effects of dexamethasone on early cognitive decline after cardiac surgery: A randomised controlled trial. Eur J Anaesthesiol 34 (2017), 776–784.
193. Nemeth, E., Vig, K., Racz, K., et al. Influence of the postoperative inflammatory response on cognitive decline in elderly patients undergoing on-pump cardiac surgery: A controlled, prospective observational study. BMC Anesthesiol, 17, 2017, 113.
194. Kumpaitiene, B., Svagzdiene, M., Drigotiene, I., et al. Correlation among decreased regional cerebral oxygen saturation, blood levels of brain injury biomarkers, and cognitive disorder. J Int Med Res 46 (2018), 3621–3629.
195. Hayashi, K., Oshima, H., Shimizu, M., et al. Preoperative 6-minute walk distance is associated with postoperative cognitive dysfunction. Ann Thorac Surg 106 (2018), 505–551.
196. Smith, P.J., Browndyke, J.N., Monge, Z.A., et al. Longitudinal changes in regional cerebral perfusion and cognition following cardiac surgery. Ann Thorac Surg 107 (2019), 112–118.
197. Jha, N., Jha, A.K., Chand Chauhan, R., et al. Maternal and fetal outcome after cardiac operations during pregnancy: A meta-analysis. Ann Thorac Surg 106 (2018), 618–626.
198. Oliver, W.C. Jr, Invited commentary. Ann Thorac Surg 106 (2018), 626–627.
199. Bhatia, M., Kidd, B., Kumar, P.A., Pro: Mechanical ventilation should be continued during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 32 (2018), 1998–2000.
200. Dryer, C., Tolpin, D., Anton, J., Con: Mechanical ventilation during cardiopulmonary bypass does not improve outcomes after cardiac surgery. J Cardiothorac Vasc Anesth 32 (2018), 2001–2004.
201. Chi, D., Chen, C., Shi, Y., et al. Ventilation during cardiopulmonary bypass for prevention of respiratory insufficiency: A meta-analysis of randomized controlled trials. Medicine (Baltimore), 96, 2017, e6454.
202. Wang, Y.C., Huang, C.H., Tu, Y.K., Effects of positive airway pressure and mechanical ventilation of the lungs during cardiopulmonary bypass on pulmonary adverse events after cardiac surgery: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth 32 (2018), 748–759.
203. Bignami, E., Guarnieri, M., Saglietti, F., et al. Different strategies for mechanical VENTilation during CardioPulmonary Bypass (CPBVENT 2014): Study protocol for a randomized controlled trial. Trials, 18, 2017, 264.
204. Fuda, G., Denault, A., Deschamps, A., et al. Risk factors involved in central-to-radial arterial pressure gradient during cardiac surgery. Anesth Analg 122 (2016), 624–632.
205. Bouchard-Dechêne, V., Couture, P., Su, A., Risk factors for radial-to-femoral artery pressure gradient in patients undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 32 (2018), 692–698.
206. Rocha Ferreira, G.S., de Almeida, J.P., Landoni, G., et al. Effect of a perioperative intra-aortic balloon pump in high-risk cardiac surgery patients: A randomized clinical trial. Crit Care Med 46 (2018), e742–e750.
207. Gatti, G., Morra, L., Castaldi, G., et al. Preoperative intra-aortic counterpulsation in cardiac surgery: Insights from a retrospective series of 588 consecutive high-risk patients. J Cardiothorac Vasc Anesth 32 (2018), 2077–2086.
208. Ad, N., Holmes, S.D., Massimiano, P.S., et al. The use of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial. J Thorac Cardiovasc Surg 155 (2018), 1011–1018.
209. Lazar, H.L., del Nido cardioplegia: Passing fad or here to stay?. J Thorac Cardiovasc Surg 155 (2018), 1009–1010.
210. Paruk, F., Sime, F.B., Lipman, J., et al. Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review. Int J Antimicrob Agents 49 (2017), 395–402.
211. Trent Magruder, J., Grimm, J.C., Dungan, S.P., et al. Continuous intraoperative cefazolin infusion may reduce surgical site infections during cardiac surgical procedures: A propensity-matched analysis. J Cardiothorac Vasc Anesth 29 (2015), 1582–1587.
212. Shoulders, B.R., Crow, J.R., Davis, S.L., et al. Impact of intraoperative continuous-infusion versus intermittent dosing of cefazolin therapy on the incidence of surgical site infections after coronary artery bypass grafting. Pharmacotherapy 36 (2016), 166–173.
213. Zhou, X., Hu, C., Xu, Z., et al. Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials. Interact Cardiovasc Thorac Surg, 2018 June 1 [E-pub ahead of print].
214. Guarracino, F., Heringlake, M., Cholley, B., et al. Use of levosimendan in cardiac surgery: An update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol 71 (2018), 1–9.
215. Hodges, K.E., Hussain, S.T., Stewart, W.J., et al. Surgical management of infective endocarditis complicated by ischemic stroke. J Card Surg 32 (2017), 9–13.
216. Ghoreishi, M., Foster, N., Pasrija, C., et al. Early operation in patients with mitral valve infective endocarditis and acute stroke is safe. Ann Thorac Surg 105 (2018), 69–75.
217. McConnell, M., Baisden, J., Duncan, A.E., Pro: Third-generation hydroxyethyl starch solution is safe and effective for plasma volume expansion during cardiac surgery. J Cardiothorac Vasc Anesth 32 (2018), 570–575.
218. Sacchet-Cardozo, F., Stoicea, N., Joseph, N., et al. Con: Hetastarch should be avoided for volume expansion in cardiac surgery patients. J Cardiothorac Vasc Anesth 32 (2018), 576–579.
219. Datzmann, T., Hoenicka, M., Reinelt, H., et al. Influence of 6% hydroxyethyl starch 130/0.4 versus crystalloid solution on structural renal damage markers after coronary artery bypass grafting: A post hoc subgroup analysis of a prospective trial. J Cardiothorac Vasc Anesth 32 (2018), 205–211.
220. Tobey, R., Cheng, H., Gao, M., et al. Postoperative acute kidney injury and blood product transfusion after synthetic colloid use during cardiac surgery. J Cardiothorac Vasc Anesth 31 (2017), 853–862.
221. Min, J.J., Cho, H.S., Jeon, S., et al. Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting: A retrospective study. Medicine (Baltimore), 96, 2017, e6801.
222. Maleki, M.H., Derakhshan, P., Sharifabad, A.R., et al. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 (Voluven) on renal function as priming solutions for cardiopulmonary bypass: A randomized double blind clinical trial. Anesth Pain Med, 6, 2016, e30326.
223. Lagny, M.G., Roediger, L., Koch, J.N., et al. Hydroxyethyl starch 130/0.4 and the risk of acute kidney injury after cardiopulmonary bypass: A single-center retrospective study. J Cardiothorac Vasc Anesth 30 (2016), 869–875.
224. Momeni, M., Nkoy Ena, L., Van Dyck, M., et al. The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study. PLoS One, 12, 2017, e0186403.
225. Svendsen, Ø.S., Farstad, M., Mongstad, A., et al. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial. Perfusion 33 (2018), 483–489.
226. Vives, M., Callejas, R., Duque, P., et al. Modern hydroxyethyl starch and acute kidney injury after cardiac surgery: A prospective multicentre cohort. Br J Anaesth 117 (2016), 458–463.
227. Williams, B., Wehman, B., Mazzeffi, M.A., et al. Acute intracardiac thrombosis and pulmonary thromboembolism after cardiopulmonary bypass: A systematic review of reported case. Anesth Analg 126 (2018), 425–434.
228. Ninh, A., Weiner, M., Goldberg, A., Healthcare-associated Mycobacterium chimaera infection subsequent to heater-cooler device exposure during cardiac surgery. J Cardiothorac Vasc Anesth 31 (2017), 1831–1835.
229. Schreiber, P.W., Sax, H., Mycobacterium chimaera infections associated with heater-cooler units in cardiac surgery. Curr Opin Infect Dis 30 (2017), 388–394.
230. Walker, J., Moore, G., Collins, S., et al. Microbiological problems and biofilms associated with Mycobacterium chimaera in heater-cooler units used for cardiopulmonary bypass. J Hosp Infect 96 (2017), 209–220.
231. Scriven, J.E., Scobie, A., Verlander, N.Q., et al. Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: Clinical features and outcome of the first 30 cases. Clin Microbiol Infect 24 (2018), 1164–1170.
232. McGoon, D.C., Pestana, C., Moffitt, E.A., Decreased risk of aortic valve surgery. Arch Surg 91 (1965), 779–786.
233. Gordon, P.C., Brink, J.G., Forty years on: The anesthetic for the world's first human-to-human heart transplant remembered. J Cardiothorac Vasc Anesth 22 (2008), 133–138.
234. Hessel, E.A. 2nd, Forty years ago: Lessons for today. J Cardiothorac Vasc Anesth 22 (2008), 3–5.
235. Morris, T., The art of medicine. Miracle in Cape Town. The Lancet 390 (2017), 2431–2432.